METALERT INC - MLRT STOCK NEWS

MetAlert, Inc. announces merger agreement with Level 2 Security, LLC to expand target market and increase revenues. Acquisition of Level 2's technology can improve P&L and Balance Sheet this fiscal year. Potential for significant growth in gun safety market. Immediate marketing campaign planned.

MetAlert announces collaboration with Next Realm AI Research Lab

MetAlert, Inc. announces its advance into AI-driven healthcare, aiming to incorporate artificial intelligence into its technology platforms. The company believes integrating AI into its products will provide predictive healthcare and capitalize on the industry expected to reach $63 billion by 2025.

MetAlert, Inc. has received a notice of allowance for its first European utility patent in the GPS SmartSole family. The patent will cover various ways to design, protect, and manufacture a GPS, Cellular, Bluetooth, and Wi-Fi monitoring electronic device embedded inside an insole, including the inductive charging unit. This is the fifth patent granted to MetAlert for tracking and monitoring devices within footwear, with a focus on the insole format.

MetAlert, Inc. (OTC: MLRT) has launched its new 4G GPS SmartSole in Denmark via its distributor, Safecall Aps, a leader in GPS telehealth products for seniors. This launch aims to support the healthcare sector, particularly for patients with mild cognitive impairment (MCI), who are more vulnerable and require assistance. The announcement highlighted that Denmark is a crucial market for GPS tracking and remote monitoring technologies, especially for Alzheimer’s and dementia care.

Andrew Duncan, the director at MetAlert, expressed excitement over fulfilling backorders and restoring normal delivery cycles as manufacturing resumes. According to the Alzheimer’s Association, about 12-18% of individuals aged 60+ live with MCI, indicating a significant potential customer base for MetAlert’s products.

MetAlert, Inc. (OTC: MLRT) has launched its 4G GPS SmartSole in the U.K. through distribution partner Possum Ltd. This innovation aims to provide location-sensitive health monitoring for individuals with mild cognitive impairment (MCI). The SmartSole features an extended battery life of up to 5 days and enhances patient independence, especially among the elderly. Andrew Duncan, Director of MetAlert, emphasizes the strategic importance of the U.K. market for health monitoring technology. Both companies anticipate strong demand and growth for the product in the coming year, aligning with rising needs for telecare solutions.